R Maller

763 total citations
28 papers, 635 citations indexed

About

R Maller is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, R Maller has authored 28 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 10 papers in Molecular Medicine and 8 papers in Infectious Diseases. Recurrent topics in R Maller's work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Antibiotic Resistance in Bacteria (10 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). R Maller is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (12 papers), Antibiotic Resistance in Bacteria (10 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). R Maller collaborates with scholars based in Sweden, Switzerland and Denmark. R Maller's co-authors include Lennart Nilsson, Håkan Hanberger, B. Isaksson, L. Sörén, Måns Nilsson, B Brodin, Lena Nilsson, Torvard C. Laurent, Sören Berg and Charles Heidelberger and has published in prestigious journals such as Cancer Research, Annals of the New York Academy of Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

R Maller

27 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Maller Sweden 14 308 191 173 161 160 28 635
C A Wood United States 11 226 0.7× 81 0.4× 177 1.0× 217 1.3× 174 1.1× 12 719
A.P. Gillett United Kingdom 10 286 0.9× 156 0.8× 109 0.6× 74 0.5× 51 0.3× 22 463
Yoshihiro Sumita Japan 13 435 1.4× 362 1.9× 169 1.0× 131 0.8× 54 0.3× 31 813
M Tanaka Japan 13 200 0.6× 186 1.0× 188 1.1× 108 0.7× 39 0.2× 23 689
E Y Ng United States 11 449 1.5× 607 3.2× 178 1.0× 292 1.8× 113 0.7× 12 1.2k
Jeffrey M. Steele United States 13 271 0.9× 111 0.6× 89 0.5× 175 1.1× 120 0.8× 32 577
Valerie Berry United States 14 161 0.5× 128 0.7× 153 0.9× 85 0.5× 23 0.1× 20 708
Monica Borgonovi Belgium 10 181 0.6× 116 0.6× 116 0.7× 169 1.0× 63 0.4× 19 423
Marc Rosen United States 5 339 1.1× 231 1.2× 157 0.9× 38 0.2× 90 0.6× 8 444
C A Knupp United States 13 308 1.0× 213 1.1× 150 0.9× 128 0.8× 45 0.3× 19 527

Countries citing papers authored by R Maller

Since Specialization
Citations

This map shows the geographic impact of R Maller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Maller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Maller more than expected).

Fields of papers citing papers by R Maller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Maller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Maller. The network helps show where R Maller may publish in the future.

Co-authorship network of co-authors of R Maller

This figure shows the co-authorship network connecting the top 25 collaborators of R Maller. A scholar is included among the top collaborators of R Maller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Maller. R Maller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maller, R, et al.. (1993). Once- versus twice-daily amikacin regimen: efficacy and safety in systemic Gram-negative infections. Journal of Antimicrobial Chemotherapy. 31(6). 939–948. 41 indexed citations
2.
Isaksson, Barbro, R Maller, Lennart Nilsson, & Maud Nilsson. (1993). Postantibiotic effect of aminogylcosides on staphylococci. Journal of Antimicrobial Chemotherapy. 32(2). 215–222. 22 indexed citations
3.
Rådberg, Gunilla, et al.. (1992). Frequencies of subpopulations of aminoglycoside- and vancomycin-resistant variants in Staphylococcus aureus and Staphylococcus epidermidis. Journal of Antimicrobial Chemotherapy. 30(4). 489–496. 3 indexed citations
4.
Maller, R, et al.. (1991). Efficacy and safety of amikacin in systemic infections when given as a single daily dose or in two divided doses. Journal of Antimicrobial Chemotherapy. 27(suppl C). 121–128. 39 indexed citations
5.
Hanberger, Håkan, Lennart Nilsson, Måns Nilsson, & R Maller. (1991). Post-antibiotic effect of beta-lactam antibiotics on gram-negative bacteria in relation to morphology, initial killing and MIC. European Journal of Clinical Microbiology & Infectious Diseases. 10(11). 927–934. 44 indexed citations
6.
Hanberger, Håkan, Lennart Nilsson, R Maller, & B. Isaksson. (1991). Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs. Antimicrobial Agents and Chemotherapy. 35(9). 1710–1716. 118 indexed citations
7.
Isaksson, B., et al.. (1991). Synergistic post-antibiotic effect of amikacin and  -lactam antibiotics on Enterococcus faecalis. Journal of Antimicrobial Chemotherapy. 27(suppl C). 9–14. 13 indexed citations
8.
Isaksson, B., Håkan Hanberger, R Maller, Lennart E. Nilsson, & Marie Nilsson. (1990). The postantibiotic effect of amikacin alone and in combination with piperacillin on gram-negative bacteria.. PubMed. 74. 129–32. 6 indexed citations
9.
Maller, R, B. Isaksson, Lena Nilsson, & L. Sörén. (1988). A study of amikacin given once versus twice daily in serious infections. Journal of Antimicrobial Chemotherapy. 22(1). 75–79. 65 indexed citations
10.
Berg, Sören, et al.. (1988). Elevated levels of plasma hyaluronan in septicaemia. Scandinavian Journal of Clinical and Laboratory Investigation. 48(8). 727–732. 72 indexed citations
11.
Brodin, B, et al.. (1985). Fibronectin and other DIC-related variables in patients with moderately severe infections receiving cryoprecipitate.. PubMed. 178. 57–65. 6 indexed citations
12.
Maller, R, et al.. (1985). Synthesis of 14C‐labelled 1‐(3,5‐bis‐trifluoromethyl)‐phenyl‐4‐methyl thiosemicarbazide, C 2696‐GO. Journal of Labelled Compounds and Radiopharmaceuticals. 22(3). 217–227. 2 indexed citations
13.
Brodin, B, et al.. (1985). Fibronectin and other DIC-related variables in septic ICU patients receiving cryoprecipitate.. PubMed. 178. 67–74. 9 indexed citations
14.
Bendi, Anjaneyulu, et al.. (1985). Synthesis of 14C‐ and 3H‐labelled 4‐(4‐nitrophenyl)aminophenylisothiocyanate (GO 9333 / CGP 4540; amoscanate. Journal of Labelled Compounds and Radiopharmaceuticals. 22(4). 313–327. 5 indexed citations
15.
Maller, R & K. Nagarajan. (1983). Synthesis of 14C‐labelled 10‐[3‐(dimethylamino)‐propyl]‐2‐nitrodibenz [b,f] [1,4] oxazepin‐11‐(10 H)‐one (nitroxazepine)hydrochloride. Journal of Labelled Compounds and Radiopharmaceuticals. 20(12). 1339–1348. 4 indexed citations
16.
Holm, S. E., et al.. (1983). A prospective, randomized study of amikacin and gentamicin in seriousinfections with focus on efficacy, toxicity and duration of serum levels above the MIC. Journal of Antimicrobial Chemotherapy. 12(4). 393–402. 23 indexed citations
17.
Bendi, Anjaneyulu, R Maller, & K. Nagarajan. (1983). Synthesis of 14C‐labelled 1‐methanesulphonyl‐3‐(1‐methyl‐5‐nitro‐1H‐imidazol‐2‐YL)‐2‐imidazolidinone, (Go 10213). Journal of Labelled Compounds and Radiopharmaceuticals. 20(8). 951–960. 1 indexed citations
18.
Keberle, H., P. Loustalot, R Maller, J. W. Faigle, & Karl Schmid. (1965). BIOCHEMICAL EFFECTS OF DRUGS ON THE MAMMALIAN CONCEPTUS. Annals of the New York Academy of Sciences. 123(1). 252–262. 18 indexed citations
19.
Ramakrishnan, T. V., et al.. (1962). Evaluation of the routes of glucose utilization in virulent and avirulent strains of Mycobacterium tuberculosis. Biochimica et Biophysica Acta. 59(2). 529–532. 9 indexed citations
20.
Maller, R & Charles Heidelberger. (1957). Studies on OPSPA. Cancer Research. 17(4). 284–290. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C A Wood Breakdown of academic impact, for papers by A.P. Gillett Breakdown of academic impact, for papers by Yoshihiro Sumita Breakdown of academic impact, for papers by M Tanaka Breakdown of academic impact, for papers by E Y Ng Breakdown of academic impact, for papers by Jeffrey M. Steele Breakdown of academic impact, for papers by Valerie Berry Breakdown of academic impact, for papers by Monica Borgonovi Breakdown of academic impact, for papers by Marc Rosen Breakdown of academic impact, for papers by C A Knupp
Rankless by CCL
2026